Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables
- PMID: 24760213
- PMCID: PMC10852089
- DOI: 10.1590/1516-3180.2014.1323568
Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables
Abstract
Context and objectives: Anemia is the most frequent extraintestinal complication of inflammatory bowel disease. This study aimed to: 1) determine the prevalence of anemia among patients with inflammatory bowel disease; 2) investigate whether routine laboratory markers are useful for diagnosing anemia; and 3) evaluate whether any association exists between anemia and clinical/laboratory variables.
Design and setting: Cross-sectional at a federal university.
Methods: 44 outpatients with Crohn's disease and 55 with ulcerative colitis were evaluated. Clinical variables (disease activity index, location of disease and pharmacological treatment) and laboratory variables (blood count, iron laboratory, vitamin B12 and folic acid) were investigated.
Results: Anemia and/or iron laboratory disorders were present in 75% of the patients with Crohn's disease and in 78.2% with ulcerative colitis. Anemia was observed in 20.5% of the patients with Crohn's disease and in 23.6% with ulcerative colitis. Iron-deficiency anemia was highly prevalent in patients with Crohn's disease (69.6%) and ulcerative colitis (76.7%). Anemia of chronic disease in combination with iron deficiency anemia was present in 3% of the patients with Crohn's disease and in 7% of the patients with ulcerative colitis. There was no association between anemia and disease location. In ulcerative colitis, anemia was associated with the disease activity index.
Conclusions: Most patients present iron laboratory disorders, with or without anemia, mainly due to iron deficiency. The differential diagnosis between the two most prevalent types of anemia was made based on clinical data and routine laboratory tests. In ulcerative colitis, anemia was associated with the disease activity index.
CONTEXTO E OBJETIVOS:: Anemia é a mais frequente complicação extraintestinal na doença inflamatória intestinal. Este estudo objetivou: 1) determinar a prevalência de anemia em portadores de doença inflamatória intestinal; 2) investigar se os marcadores laboratoriais de uso rotineiro são úteis para o diagnóstico da anemia; 3) avaliar se existe associação entre anemia e variáveis clínico-laboratoriais.
TIPO DE ESTUDO E LOCAL:: Estudo transversal em uma universidade federal.
MÉTODOS:: Foram avaliados 44 pacientes ambulatoriais com doença de Crohn e 55 com retocolite ulcerativa. Foram investigados aspectos clínicos (índice de atividade da doença, localização da doença e tratamento farmacológico) e laboratoriais (hemograma, ferrocinética, vitamina B12 e ácido fólico).
RESULTADOS:: Anemia e/ou anormalidades na ferrocinética estavam presentes em 75% dos pacientes com doença de Crohn e em 78,2% dos pacientes com retocolite. Anemia foi observada em 20,5% do grupo com doença de Crohn e em 23,6% do grupo com retocolite. Anemia por deficiência de ferro predominou entre os pacientes com doença de Crohn (69,6%) e com retocolite (76,7%). Anemia de doença crônica associada à anemia ferropriva estava presente em 3% dos pacientes com doença de Crohn e em 7% daqueles com retocolite. Na retocolite, a anemia estava associada com o índice de atividade da doença.
CONCLUSÕES:: A maioria dos pacientes apresentava alterações na ferrocinética com ou sem anemia, principalmente decorrente da ferropenia. O diagnóstico diferencial entre os dois tipos mais prevalentes de anemia foi baseado nos dados clínicos e nos testes laboratoriais de rotina. Anemia estava associada com o índice de atividade na retocolite.
Conflict of interest statement
Similar articles
-
[Anemia classification, prevalence and predictive factors in inflammatory bowel disease].Orv Hetil. 2025 Jan 12;166(2):60-66. doi: 10.1556/650.2025.33197. Print 2025 Jan 12. Orv Hetil. 2025. PMID: 39799539 Hungarian.
-
The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia.Scand J Gastroenterol. 2011 Mar;46(3):304-9. doi: 10.3109/00365521.2010.533382. Epub 2010 Nov 15. Scand J Gastroenterol. 2011. PMID: 21073374
-
Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.J Crohns Colitis. 2010 Dec;4(6):642-8. doi: 10.1016/j.crohns.2010.07.008. Epub 2010 Aug 12. J Crohns Colitis. 2010. PMID: 21122574
-
Familial occurrence and inheritance studies in inflammatory bowel disease.Neth J Med. 1996 Feb;48(2):53-6. doi: 10.1016/0300-2977(95)00093-3. Neth J Med. 1996. PMID: 8819799 Review.
-
Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review.Nutrients. 2021 Nov 10;13(11):4008. doi: 10.3390/nu13114008. Nutrients. 2021. PMID: 34836263 Free PMC article. Review.
Cited by
-
Biomarkers and Hematological Indices in the Diagnosis of Iron Deficiency in Children with Inflammatory Bowel Disease.Nutrients. 2020 May 9;12(5):1358. doi: 10.3390/nu12051358. Nutrients. 2020. PMID: 32397525 Free PMC article.
-
PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN'S DISEASE.Arq Bras Cir Dig. 2020 Nov 20;33(2):e1522. doi: 10.1590/0102-672020200002e1522. eCollection 2020. Arq Bras Cir Dig. 2020. PMID: 33237166 Free PMC article.
-
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide.Gastroenterol Res Pract. 2017;2017:8646495. doi: 10.1155/2017/8646495. Epub 2017 Jan 3. Gastroenterol Res Pract. 2017. PMID: 28127306 Free PMC article.
-
Increased DMT1 and FPN1 expression with enhanced iron absorption in ulcerative colitis human colon.Am J Physiol Cell Physiol. 2020 Feb 1;318(2):C263-C271. doi: 10.1152/ajpcell.00128.2019. Epub 2019 Nov 13. Am J Physiol Cell Physiol. 2020. PMID: 31721611 Free PMC article.
-
Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014.BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000155. doi: 10.1136/bmjgast-2017-000155. eCollection 2017. BMJ Open Gastroenterol. 2017. PMID: 28944071 Free PMC article.
References
-
- Kornbluth A, Sachar DB, Salomon P. Crohn's disease. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Gastrointestinal and liver disease. th. Philadelphia: Saunders; 1998. pp. p. 1708–p. 1734.
-
- Miszputen SJ, Cutait R. Doenças inflamatórias intestinais. In: Prado FC, Ramos J, Ribeiro do Valle J, editors. Atualização terapêutica. rd. São Paulo: Artes Médicas; 2007. pp. p. 399–p. 405.
-
- Jewell DP. Ulcerative colitis. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Gastrointestinal and liver disease. th. Philadelphia: Saunders; 1998. pp. p. 1735–p. 1761.
-
- Cronin CC, Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol. 2001;96(8):2296–2298. - PubMed
-
- Gasché C, Reinisch W, Lochs H, et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci. 1994;39(9):1930–1934. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical